Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT07419087
Recruiting Not applicable

Trunk Impairment Scale - Adaptation and Validation in French

NCT07419087 · tracked via the Priya Life Science France tracker
Sponsor
Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape
Phase
Not applicable
Started
2026-03-19
Last updated
2026-06-24

Condition(s) studied

Stroke (CVA) or Transient Ischemic AttackStroke (CVA) or TIA

Investigational drug(s) / intervention(s)

Evaluation by the TIS

Evaluation by the TIS: The participant will be evaluated using the TIS on two consecutive days. An evaluation will be conducted by two different evaluators.

Study summary

The objective of this project is to verify the validity and determine the clinimetric properties after translation and adaptation into French of the Trunk Impairment Scale (TIS), a scale for measuring trunk control and seated balance.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion criteria (Phase 1): * Patients over 18 years of age * Patients who have had a stroke * Full understanding of the French language * No cognitive disorders * No prior exposure to the TIS scale * Covered by a social security system * Having been informed, having agreed to participate in the study, and having signed the free and informed consent form. Inclusion criteria (Phase 2): * Patients aged over 18 and under 85 years * Having had a stroke, with no time-since-onset limitation * Able to sit for 10 seconds without hand support * Able to provide informed consent * With an NIHSS score between 2 and 26 * Covered by a social security system * Having been informed, having agreed to participate in the study, and having signed the free and informed consent form Exclusion Criteria (Phase 1): * Insufficient command of the French language * Inability to understand instructions * Persons deprived of liberty (by judicial or administrative decision) * Adults under legal protection or unable to express their consent * Pregnant or breastfeeding women Exclusion Criteria (Phase 2): * Contraindication to the sitting position or to hip adduction (hip prosthesis) * History of orthopedic or neurological disorders affecting sitting balance * Insufficient command of the French language * Inability to understand instructions * Person deprived of liberty (by judicial or administrative decision) * Adult under legal protection or unable to express consent * Pregnant or breastfeeding woman

Primary outcome measure(s)

  • Content validity — Through Phase 1 completion (up to 6 months)
    he validity of the content is evaluated at four levels, described in detail in the methodology section of the translation and cross-cultural adaptation phase: By the reading committee (for the translation, reconciliation, and back-translation phases) By a group of professional experts in the field (to approve or not the pre-final versions) By comparing the items of the original TIS with its back-translation, by Prof. Verheyden and his team By a cognitive interview with patients, to assess the proper understanding of each item.

Trial sites (1)

FacilityCityRegionStatus
Centre de Kerpape Ploemeur Please Choose... Recruiting

More Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape trials in France

Impact of Compression Garments on Pain in Patients With Complex Regional Pain Syndrome of the Upper Limbs. Recruiting
Ecological Test Standardization for Concussion Assessment in Football Players Recruiting
Personal Exoskeleton or Manual Wheelchair: a Comparison of Performance and Satisfaction in Activities of Daily Living Among People With Spinal Cord Injuries, Using the SCED Methodology. Starting soon
Identification of Responders to Platelet-Rich Plasma (PRP) Injections in Lateral Elbow Epicondylalgia Recruiting

Other trials for the same condition

Early Functional Proprioceptive Stimulation Post-stroke Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07419087 on ClinicalTrials.gov ↗ ← All trials in France